+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Thailand Infection Control Market - Forecasts form 2020 to 2025

  • ID: 5020061
  • Report
  • April 2020
  • Region: Thailand
  • 83 Pages
  • Knowledge Sourcing Intelligence LLP

FEATURED COMPANIES

  • 3M
  • B. Braun Melsungen AG
  • Schülke & Mayr GmbH
  • STERIS plc
  • Tuttnauer
The Thailand infection control market is estimated to hold a market size of US$39.616 million in 2019. The fastest-growing healthcare sector in Thailand, projected to be one of the major economic drivers of the country is driving the market growth in the forecast period. The growing medical tourism in the country is further providing an impetus for propagating the growth of the infection control market. The growth of private hospitals supported by investments is augmenting the market demand in the forecast period. HIV/AIDS is a major health issue in Thailand, hence, big health organizations like CDC through their HIV programs are providing technical assistance encouraging access to HIV prevention services, early disease diagnosis, and improving the quality of HIV care and treatment services. The prevalence of HIV/AIDS is propelling the market demand over the next five years. The prevalence of cardiovascular diseases, cancer, and incidences of road traffic injuries are further contributing to increasing the sales of infection control products in the country.

The growing number of private hospitals in the country is providing an opportunity for the market to thrive in the forecast period.

As per the Ministry of Public Health estimates, in 2015, it was recorded that around 343 private hospitals were operating in the country, in 2011, it was recorded that the number of operating private hospitals were around 321. Maximum private hospitals accounting for a share of around 40% are estimated to operate in the Bangkok metropolitan area. The private hospitals in Thailand are undergoing structural changes where it is observed that large hospitals are expanding rapidly through strategic mergers and acquisitions, in addition to increasing their commercial networks in Bangkok and in other regions. The growth of the private hospitals in the country is projected to continue with increased competitiveness in the forecast period due to the entry of non-traditional players which include huge aggregate companies. Furthermore, realizing the potential opportunities, some public companies have developed specialized services in order to match private hospital standards.

The growing medical tourism is further providing an opportunity for the market to proliferate in the forecast period and in the upcoming years.

Thailand is gaining popularity as a prime destination for cosmetic surgeries and treatment procedures. There are around 64 hospitals having Joint Commission International, JCI accredited medical facilities, burgeoning the growth of medical tourism in the country. It has been estimated that Thailand receives more than 300,000 medical tourists every year spending on treatments in several hospitals and clinics. The common cosmetic procedures include CoolSculpting, breast augmentation procedures which is the most common one, the Brazilian butt lift, and labiaplasty. The Thai government is capitalizing on the development of the medical tourism industry through a number of incentives. The shift in public policy in order to create a favourable environment for medical tourists is being observed. This is done so that medical tourists are able to avail all the medical services easily. Additionally, certain initiatives including the loosening of visa restrictions, in addition to the creation of smart visas are a part of the government strategic plan. To increase treatment options and attract customers from abroad, efforts are being made towards visa extension from 30 to 90 days for Chinese citizens, and the citizens of Cambodia, Laos, Myanmar, and Vietnam and promising quality medical facilities.

Segmentation:

By Product
  • Disinfectant
  • Sterilization
  • Low temperature Sterilization
  • Heat Sterilization
  • Contract Sterilization

By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • B. Braun Melsungen AG
  • Schülke & Mayr GmbH
  • STERIS plc
  • Tuttnauer

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. Thailand Infection Control Market Analysis, by Product
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. Thailand Infection Control Market Analysis, by End User Industry
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. Company Profiles
8.1. 3M
8.2. Schülke & Mayr GmbH
8.3. Tuttnauer
8.4. B. Braun Melsungen AG
8.5. STERIS plc
8.6. List is not Exhaustive*
Note: Product cover images may vary from those shown
  • 3M
  • Schülke & Mayr GmbH
  • Tuttnauer
  • B. Braun Melsungen AG
  • STERIS plc
Note: Product cover images may vary from those shown